Core Insights - First Guaranty Bancshares (FGBI) shares increased by 19.7% to close at $6.44, supported by high trading volume, and have gained 22% over the past four weeks [1][2] Company Performance - The bank is expected to report a quarterly loss of $0.29 per share, reflecting a year-over-year decline of 1066.7%, with revenues projected at $24.46 million, down 2.5% from the previous year [3] - The consensus EPS estimate for FGBI has remained unchanged over the last 30 days, indicating a lack of upward revisions which typically correlate with stock price movements [4] Insider Activity - Substantial insider buying on December 31, 2025, has positively influenced market sentiment, suggesting strong insider confidence in the bank's turnaround strategy following an unexpected loss in Q3 2025 [2] Industry Context - FGBI is part of the Zacks Banks - Southeast industry, where another company, First Bancorp (FBP), saw a 1.5% increase in its stock price, closing at $21.22, and has returned 4% over the past month [4] - First Bancorp's consensus EPS estimate has remained unchanged at $0.51, representing a year-over-year increase of 10.9%, and it currently holds a Zacks Rank of 4 (Sell) [5]

Axsome Therapeutics (AXSM) shares rallied 22.8% in the last trading session to close at $182.64. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.7% gain over the past four weeks.The stock rallied after the company announced that the FDA has accepted and granted priority review to its supplemental new drug application seeking approval for AXS-05 as a treatment for Alzheimer’s disease agitation. A final decis ...

Core Viewpoint - Analysts expect ABM Industries to report quarterly earnings of $1.10 per share, reflecting a year-over-year increase of 22.2%, with revenues projected at $2.27 billion, up 4.2% from the previous year [1]. Revenue Estimates - Revenues from Business & Industry are expected to reach $1.04 billion, indicating a year-over-year change of +1.7% [4]. - Revenues from Aviation are forecasted at $290.34 million, showing a year-over-year increase of +5% [4]. - Revenues from Education are projected to be $236.37 million, reflecting a year-over-year change of +2.8% [4]. - Revenues from Manufacturing & Distribution are estimated at $403.50 million, indicating a year-over-year change of +4.1% [5]. - Revenues from Technical Solutions are expected to arrive at $298.84 million, showing a significant year-over-year increase of +16.1% [5]. Operating Profit Estimates - Operating profit for Business & Industry is expected to be $111.70 million, compared to $72.00 million in the same quarter last year [6]. - Operating profit for Aviation is projected at $24.47 million, up from $18.60 million in the previous year [6]. - The consensus estimate for Operating profit in Manufacturing & Distribution stands at $51.21 million, compared to $40.40 million a year ago [7]. - Analysts expect Operating profit for Technical Solutions to reach $34.23 million, up from $28.00 million in the same quarter last year [7]. - The estimated Operating profit for Education is $19.40 million, contrasting with the year-ago figure of $13.10 million [8]. Stock Performance - Shares of ABM Industries have shown a return of +10.7% over the past month, outperforming the Zacks S&P 500 composite, which changed by +0.9% [8].

In its upcoming report, Vail Resorts (MTN) is predicted by Wall Street analysts to post quarterly loss of -$5.23 per share, reflecting a decline of 13.5% compared to the same period last year. Revenues are forecasted to be $271.27 million, representing a year-over-year increase of 4.2%.The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during ...

Core Insights - Analysts expect Abercrombie & Fitch (ANF) to report quarterly earnings of $2.15 per share, reflecting a year-over-year decline of 14% [1] - Revenue is projected to be $1.28 billion, indicating a 5.5% increase from the same quarter last year [1] - The consensus EPS estimate has been revised 2% lower over the past 30 days, indicating a reevaluation of initial estimates by analysts [1][2] Revenue and Sales Estimates - Analysts estimate 'Net sales - Hollister' to reach $637.90 million, representing a year-over-year increase of 10.2% [4] - 'Net sales - Abercrombie' is projected to be $634.64 million, showing a slight increase of 0.8% from the previous year [4] - The total number of stores at the end of the period (EOP) is expected to be 819, up from 770 in the same quarter last year [4] Comparable Store Sales - The estimated 'Comparable store sales - Total - YoY change' is 3.5%, a significant decrease from the previous year's figure of 16.0% [5] - 'Comparable store sales - Abercrombie - YoY change' is forecasted to be -4.4%, down from 11.0% in the same quarter last year [5] - Analysts predict 'Comparable store sales - Hollister - YoY change' to be 10.0%, compared to 21.0% reported in the same quarter last year [6] Stock Performance - Over the past month, Abercrombie shares have gained 1.9%, while the Zacks S&P 500 composite has decreased by 0.3% [6] - Based on its Zacks Rank 3 (Hold), ANF is expected to perform in line with the overall market in the upcoming period [6]

Core Insights - Spire Inc. (NYSE: SR) is a significant player in the energy sector, focusing on natural gas distribution [1][5] - Morgan Stanley has set a price target of $91 for Spire Inc., indicating a potential price increase of approximately 4.59% from its current price of $87 [1][5] - The company is preparing to host a conference call on November 14, 2025, to discuss its fiscal 2025 fourth quarter and year-end financial results, which may influence its stock price [3][5] Stock Performance - As of now, Spire Inc.'s stock is priced at $86.93, reflecting a slight increase of 0.06% or $0.055 today [2] - The stock has experienced a trading range between $86.52 and $87.21 for the day, with a yearly high of $87.64 and a low of $61.87, indicating volatility [2] Market Metrics - The company's market capitalization is approximately $5.13 billion, with a trading volume of 60,011 shares, suggesting moderate investor interest [4][5]

Company Overview - Vir Biotechnology, Inc. (VIR) shares increased by 6.9% to close at $6.05, supported by high trading volume, and have gained 8% over the past four weeks [1] - The rise in stock price is linked to positive investor sentiment regarding the company's late-stage pipeline candidate, tobevibart, aimed at treating chronic hepatitis delta [1] Financial Performance - The company is projected to report a quarterly loss of $0.70 per share, reflecting a year-over-year increase of 55.1% [2] - Expected revenues are $7.04 million, which is a significant increase of 195.6% compared to the same quarter last year [2] Earnings Estimates - The consensus EPS estimate for Vir Biotechnology has remained unchanged over the last 30 days, indicating stability in earnings expectations [3] - A stock's price typically does not continue to rise without trends in earnings estimate revisions, suggesting the need for monitoring future developments for VIR [3] Industry Context - Vir Biotechnology is categorized under the Zacks Medical - Biomedical and Genetics industry, which includes other companies like Tarsus Pharmaceuticals, Inc. (TARS) [4] - Tarsus Pharmaceuticals has seen a 1.9% increase in its stock price, closing at $69.75, with a notable return of 21.1% over the past month [4] Comparative Analysis - Tarsus Pharmaceuticals has a consensus EPS estimate of -$0.38, which is a 37.7% improvement from the previous year [5] - Tarsus currently holds a Zacks Rank of 4 (Sell), contrasting with Vir Biotechnology's Zacks Rank of 3 (Hold) [4][5]

Core Viewpoint - Kinsale Capital Group, Inc. (KNSL) has shown strong stock performance, with a recent increase of 5.4% to close at $466.26, following a period of decline, supported by solid trading volume and positive analyst ratings [1][2]. Group 1: Stock Performance - Kinsale Capital shares surged after Truist Securities reiterated its "Buy" rating and set a price target of $560, following positive meetings with management [2]. - The stock experienced a 3.7% loss over the past four weeks before the recent surge [1]. Group 2: Growth and Market Position - Kinsale Capital has strengthened its presence in the U.S. excess and surplus (E&S) market through consistent premium growth, healthy broker submissions, solid renewal activity, and disciplined underwriting [3]. - The company aims for long-term top-line growth of 10% to 20% [2]. Group 3: Financial Performance Expectations - Kinsale Capital is expected to report quarterly earnings of $4.66 per share, reflecting an 11% year-over-year increase, with revenues projected at $449.2 million, up 7.5% from the previous year [4]. - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in earnings expectations [6]. Group 4: Industry Context - Kinsale Capital Group is part of the Zacks Insurance - Property and Casualty industry, which includes other companies like Palomar (PLMR), which recently closed 3.8% higher [7].

Company Overview - Dave Inc. (DAVE) shares increased by 4.7% to close at $238.54, with notable trading volume exceeding typical levels [1] - The stock has gained 22.3% over the past four weeks, driven by a $125 million share repurchase program and an increase in 2025 revenue guidance to $505–$515 million [1] Earnings Expectations - The company is projected to report quarterly earnings of $2.09 per share, reflecting a year-over-year increase of 38.4% [2] - Expected revenues for the upcoming quarter are $131.17 million, which is a 41.8% increase compared to the same quarter last year [2] Stock Performance Insights - The consensus EPS estimate for DAVE has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting positive investor sentiment [4] Industry Comparison - DAVE is part of the Zacks Technology Services industry, where Kyndryl Holdings, Inc. (KD) has a Zacks Rank of 4 (Sell) and reported a 0.4% decrease in its last trading session [4][5] - Kyndryl's consensus EPS estimate has remained unchanged at $0.33, representing a significant year-over-year change of +3200% [5]

Core Viewpoint - Darden Restaurants (DRI) is expected to report quarterly earnings of $1.99 per share, reflecting a year-over-year increase of 13.7%, with revenues projected at $3.04 billion, up 10.2% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised downward by 0.3% in the last 30 days, indicating a reassessment by analysts [1][2] - Changes in earnings projections are crucial for predicting investor reactions and short-term stock price movements [2] Sales Estimates - Analysts estimate 'Sales- Olive Garden' to reach $1.31 billion, indicating a year-over-year change of +7.9% [3] - 'Sales- Other Business' is projected at $665.09 million, reflecting a year-over-year increase of +19.7% [4] - 'Sales- Fine Dining' is expected to be $290.21 million, showing a +4.1% change from the prior year [4] - 'Sales- LongHorn Steakhouse' is estimated at $783.54 million, indicating a +9.8% change from the previous year [4] Company-Owned Restaurants - Total company-owned restaurants are expected to reach 2,167, up from 2,040 a year ago [5] - Same-restaurant sales for LongHorn Steakhouse are projected to increase by 5.8%, compared to 3.7% in the previous year [5] - Company-owned restaurants for LongHorn Steakhouse are estimated at 594, up from 577 in the same quarter last year [5] - Olive Garden's company-owned restaurants are expected to be 936, compared to 923 a year ago [6] - Ruth's Chris Steak House is projected at 83, up from 82 last year [6] - Bahama Breeze is expected to have 28 company-owned restaurants, down from 44 in the previous year [6] - Seasons 52 is projected at 43, compared to 44 last year [7] - Eddie V's is expected to remain at 29, unchanged from the previous year [7] Stock Performance - Darden Restaurants shares have increased by +2.5% in the past month, slightly outperforming the +2.3% move of the Zacks S&P 500 composite [8] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to mirror overall market performance in the near future [8]